DLEU2 has been verified as a proliferation-inducing lncRNA in the vast majority of cancer types (13 out of 16) (Ghafouri-Fard et al., 2021), and TMPO-AS1 has a role in tumorigenesis and progression and is overexpressed in 15 different cancer types (Zheng et al., 2021). The gene discussed is TMPO; the disease is cancer.